Physical disease in schizophrenia: a population-based analysis in Spain

Bouza, Carmen; López-Cuadrado, Teresa; Amate, José María
January 2010
BMC Public Health;2010, Vol. 10 Issue 1, p745
Academic Journal
Background: Physical disease remains a challenge in patients with schizophrenia. Our objective was to determine the epidemiological characteristics and burden of physical disease in hospitalized patients with schizophrenia. Methods: We analyzed the 2004 Spanish National Hospital Discharge Registry, identified records coded for schizophrenia (295.xx) and characterized the physical diseases using the ICD-9 system and the Charlson Index. We also calculated standardized mortality ratios (SMRs) versus the general population adjusted by age and calendar time. Results: A total of 16, 776 cases (mean age: 43 years, 65% males) were considered for analysis. Overall, 61% of cases had at least one ICD-9 physical code and 32% had more than one ICD-9 code. The Charlson index indicated that 20% of cases had a physical disease of known clinical impact and prognostic significance. Physical disease appeared early in life (50% of cases were 15-31 years of age) and increased rapidly in incidence with age. Thus, for patients aged 53 years or more, 84% had at least one physical ICD-9 code. Apart from substance abuse and addiction, the most prevalent diseases were endocrine (16%), circulatory (15%), respiratory (15%), injury-poisoning (11%), and digestive (10%). There were gender-related differences in disease burden and type of disease. In-hospital mortality significantly correlated with age, the Charlson Index and several ICD-9 groups of physical disease. Physical disease was associated with an overall 3.6-fold increase in SMRs compared with the general population. Conclusions: This study provides the first nationally representative estimate of the prevalence and characteristics of physical disease in hospitalized patients with schizophrenia in Spain. Our results indicate that schizophrenia is associated with a substantial burden of physical comorbidities; that these comorbidities appear early in life; and that they have a substantial impact on mortality. This information raises concerns about the consequences and causes of physical disorders in patients with schizophrenia. Additionally, it will help to guide the design and implementation of preventive and therapeutic programs from the viewpoint of clinical care and in terms of healthcare service planning.


Related Articles

  • Consenso sobre la salud física del paciente con esquizofrenia de las Sociedades Españolas de Psiquiatría y de Psiquiatría Biológica. Ruiz, J. Sáiz; García, J. Bobes; Ruiloba, J. Vallejo; Ubago, J. Giner; González, M. P. García-Portilla // Actas Espanolas de Psiquiatria;sep2008, Vol. 36 Issue 5, p31 

    Introduction. Schizophrenia has traditionally been associated with higher rates of physical comorbidity and excess mortality. Objective. To develop a Spanish consensus document concerning the physical health of patients with schizophrenia and the interventions required to reduce the...

  • Poor physical health and mortality in patients with schizophrenia. Pack, Steven // Nursing Standard;1/28/2009, Vol. 23 Issue 21, p41 

    Schizophrenia, its treatment and the lifestyle of patients contribute to high rates of mortality. Patients often have poorer diets, lower rates of physical activity and smoke more than the general population. Such lifestyle choices predispose them to physical health problems and disease. This...

  • The cost reduction in hospitalization associated with paliperidone palmitate in the People's Republic of China, Korea, and Malaysia. Chiun-Fang Chiou; Wang, Bruce C. M.; Caldwell, Ronald; Furnback, Wesley; Jung-Sun Lee; Kothandaraman, Nathan; SunKyoung Lee; Jin Wang; Fan Zhang // Neuropsychiatric Disease & Treatment;Aug2015, Vol. 11, p1989 

    Background: Schizophrenia results in substantial health care utilization costs. Much of these costs can be attributed to health care use resulting from nonadherence to treatment, relapse, and hospitalization. Aims of the study: The objective of this research is to further estimate the health...

  • Mortality and guideline-concordant care for older patients with schizophrenia: a retrospective longitudinal study. Tsan, Jack Y.; Stock, Eileen M.; Gonzalez, Jazmin M.; Greenawalt, David S.; Zeber, John E.; Rouf, Emran; Copeland, Laurel A. // BMC Medicine;2012, Vol. 10 Issue 1, p147 

    Background: Schizophrenia is associated with excess mortality and multimorbidity, which is possibly associated with difficulty in coordinating care for multiple mental and physical comorbidities. We analyzed the receipt by patients with schizophrenia of 11 types of guideline-concordant care and...

  • Clozapine and Dilated Cardiomyopathy. Meyer, Jonathan M.; Rao, Sanjai D.; Nielsen, Jimmi R. // Clinical Schizophrenia & Related Psychoses;Jul2007, Vol. 1 Issue 2, p175 

    Clozapine is effective in treatment-resistant schizophrenia, but carries a number of risks, including the rare but potentially fatal complication of cardiomyopathy. We report the case of a long-term inpatient with schizophrenia who improved significantly with clozapine therapy, but eighteen...

  • Relationship between cognitive insight and subjective quality of life in outpatients with schizophrenia. Jong-Hoon Kim; Seul Lee; Ah-Young Han; Kyungwook Kim; Jinyoung Lee // Neuropsychiatric Disease & Treatment;Aug2015, Vol. 11, p2041 

    Background: The concept of cognitive insight refers to the cognitive processes involved in patients' re-evaluation of their anomalous experiences and of their misinterpretations. The purpose of the present study was to examine the relationship between cognitive insight and subjective quality of...

  • Ten-Year Quality-of-Life Outcomes of Patients with Schizophrenia and Schizoaffective Disorders: The Relationship with Unmet Needs for Care. Ritsner, Michael S.; Grinshpoon, Alexander // Clinical Schizophrenia & Related Psychoses;Fall2015, Vol. 9 Issue 3, p125 

    Purpose: The present study examined the relationship between unmet needs and current as well as long-term quality of life (QOL) of patients with schizophrenia (SZ) and schizoaffective (SA) disorders. Methods: Ninety-five stable SZ/SA patients were evaluated using the Quality of Life Enjoyment...

  • Direct costs of schizophrenia in Italian community psychiatric services. Garattini, L.; Rossi, C.; Tediosi, F.; Cornaggia, C.; Covelli, G.; Barbui, C.; Parazzini, F. // PharmacoEconomics;Dec2001, Vol. 19 Issue 12, p1217 

    Objective: To estimate resource utilisation and direct costs of treatment for patients with schizophrenia in Italian Community Mental Health Centers (CMHCs).Design: Multicentre, retrospective observational study. CMHCs recruited all patients who attended a follow-up...

  • Managing Schizophrenia During the Stable Phase: Is There Consensus Among Practice Guidelines? Bhanji, Nadeem H.; Tempier, Raymond // Canadian Journal of Psychiatry;Feb2002, Vol. 47 Issue 1, p76 

    Evaluates the importance of clinical practice guidelines (CPG) in the management of schizophrenia at a stable phase. Emphasis on antipsychotic therapy and psychosocial interventions in CPG; Areas insufficiently addressed by CPG; Pros and cons of CPG.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics